← ANALYST RATINGS · TIPRANKS
Cytokinetics (CYTK): analyst forecast and price target
Price targets and ratings of
Analyst consensus
Strong Buy16 Buy1 Hold0 Sell
Ratings of 17 analysts in the last 3 months12-month forecast
$111+78.6% upside
Based on 17 price targets given in the last 3 months, the average target is $111, the highest $146, the lowest $85.00. The average is +78.6% from the last price of $61.95.
Highest target $146
Average target $111
Lowest target $85.00
Analyst ratings 30
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| AI xAi BiotechnologyxAI Grok-4 | TipRanks - xAI | $63.00 → $61.00−3.2% | Hold | −1.5% | Reiterated | 17.10.26on TipRanks 03:05 | — | |
| AI DeepSeek BiotechnologyDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $63.00 → $62.00−1.6% | Hold | +0.1% | Reiterated | 17.10.26on TipRanks 03:05 | — | |
| AI OpenAI BiotechnologyOpenAI 5.2 | TipRanks - OpenAI | $63.00 → $62.00−1.6% | Hold | +0.1% | Reiterated | 17.10.26on TipRanks 03:05 | — | |
| AI Anthropic BiotechnologyAnthropic Opus-4.6 | TipRanks - Anthropic | $63.00 → $61.00−3.2% | Hold | −1.5% | Reiterated | 17.10.26on TipRanks 03:05 | — | |
| AI Google BiotechnologyGemini 3.1Pro | TipRanks - Google | $67.00 → $65.00−3.0% | Hold | +4.9% | Reiterated | 17.10.26on TipRanks 03:05 | — | |
| AI PerPlexity BiotechnologyPerPlexity SonarPro | TipRanks - PerPlexity | $63.00 → $62.00−1.6% | Hold | +0.1% | Reiterated | 17.10.26on TipRanks 03:05 | — | |
| AI xAi BiotechnologyxAI Grok-4 | TipRanks - xAI | $61.00 → $63.00+3.3% | Hold | +1.7% | Reiterated | 16.10.26on TipRanks Oct 15 22:05 | — | |
| AI DeepSeek BiotechnologyDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $61.00 → $63.00+3.3% | Hold | +1.7% | Reiterated | 16.10.26on TipRanks Oct 15 22:05 | — | |
| AI OpenAI BiotechnologyOpenAI 5.2 | TipRanks - OpenAI | $61.00 → $63.00+3.3% | Hold | +1.7% | Reiterated | 16.10.26on TipRanks Oct 15 22:05 | — | |
| AI Anthropic BiotechnologyAnthropic Opus-4.6 | TipRanks - Anthropic | $61.00 → $63.00+3.3% | Hold | +1.7% | Reiterated | 16.10.26on TipRanks Oct 15 22:05 | — | |
| AI Google BiotechnologyGemini 3.1Pro | TipRanks - Google | $65.00 → $67.00+3.1% | Hold | +8.2% | Reiterated | 16.10.26on TipRanks Oct 15 22:05 | — | |
| AI PerPlexity BiotechnologyPerPlexity SonarPro | TipRanks - PerPlexity | $61.00 → $63.00+3.3% | Hold | +1.7% | Reiterated | 16.10.26on TipRanks Oct 15 22:05 | — | |
| Unknown Analyst | William Blair | — | Buy | — | Initiated | 15.10.26on TipRanks 22:05 | −2.0% | ↗ |
| Leonid Timashev★★★★★★★★★★#279 · hits 60% · avg +24.5% | RBC Capital | $113 | Buy | +82.4% | Reiterated | 14.10.26on TipRanks Oct 15 08:10 | +4.0%next day +0.5% | ↗ |
| AI xAi BiotechnologyxAI Grok-4 | TipRanks - xAI | $62.00 → $61.00−1.6% | Hold | −1.5% | Reiterated | 14.10.26on TipRanks 16:05 | — | |
| AI DeepSeek BiotechnologyDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $62.00 → $61.00−1.6% | Hold | −1.5% | Reiterated | 14.10.26on TipRanks 16:05 | — | |
| AI OpenAI BiotechnologyOpenAI 5.2 | TipRanks - OpenAI | $62.00 → $61.00−1.6% | Hold | −1.5% | Reiterated | 14.10.26on TipRanks 16:05 | — | |
| AI Anthropic BiotechnologyAnthropic Opus-4.6 | TipRanks - Anthropic | $62.00 → $61.00−1.6% | Hold | −1.5% | Reiterated | 14.10.26on TipRanks 16:05 | — | |
| AI Google BiotechnologyGemini 3.1Pro | TipRanks - Google | $66.00 → $65.00−1.5% | Hold | +4.9% | Reiterated | 14.10.26on TipRanks 16:05 | — | |
| AI PerPlexity BiotechnologyPerPlexity SonarPro | TipRanks - PerPlexity | $62.00 → $61.00−1.6% | Hold | −1.5% | Reiterated | 14.10.26on TipRanks 16:05 | — | |
| Tessa Romero★★★★★★★★★★#805 · hits 57% · avg +21.7% | J.P. Morgan | — | Buy | — | Reiterated | 14.10.26on TipRanks 08:25 | +4.0%next day +0.5% | ↗ |
| Ashwani Verma★★★★★★★★★★#1305 · hits 60% · avg +13.4% | UBS | $115 → $104−9.6% | Buy | +67.9% | Reiterated | 14.10.26on TipRanks 07:15 | +4.0%next day +0.5% | ↗ |
| AI DeepSeek BiotechnologyDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $63.00 → $62.00−1.6% | Hold | +0.1% | Reiterated | 13.10.26on TipRanks 11:06 | — | |
| AI OpenAI BiotechnologyOpenAI 5.2 | TipRanks - OpenAI | $63.00 → $62.00−1.6% | Hold | +0.1% | Reiterated | 13.10.26on TipRanks 11:06 | — | |
| AI PerPlexity BiotechnologyPerPlexity SonarPro | TipRanks - PerPlexity | $63.00 → $62.00−1.6% | Hold | +0.1% | Reiterated | 13.10.26on TipRanks 11:06 | — | |
| Joseph Pantginis★★★★★★★★★★#243 · hits 55% · avg +24.8% | H.C. Wainwright | $140 | Buy | +126.0% | Reiterated | 13.10.26on TipRanks 06:26 | −1.9%next day +4.0% | ↗ |
| AI xAi BiotechnologyxAI Grok-4 | TipRanks - xAI | $61.00 → $62.00+1.6% | Hold | +0.1% | Reiterated | 12.10.26on TipRanks 01:05 | — | |
| AI DeepSeek BiotechnologyDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $62.00 → $63.00+1.6% | Hold | +1.7% | Reiterated | 12.10.26on TipRanks 01:05 | — | |
| AI OpenAI BiotechnologyOpenAI 5.2 | TipRanks - OpenAI | $62.00 → $63.00+1.6% | Hold | +1.7% | Reiterated | 12.10.26on TipRanks 01:05 | — | |
| AI Anthropic BiotechnologyAnthropic Opus-4.6 | TipRanks - Anthropic | $61.00 → $62.00+1.6% | Hold | +0.1% | Reiterated | 12.10.26on TipRanks 01:05 | — | |
| AI Google BiotechnologyGemini 3.1Pro | TipRanks - Google | $65.00 → $66.00+1.5% | Hold | +6.5% | Reiterated | 12.10.26on TipRanks 01:05 | — | |
| AI PerPlexity BiotechnologyPerPlexity SonarPro | TipRanks - PerPlexity | $62.00 → $63.00+1.6% | Hold | +1.7% | Reiterated | 12.10.26on TipRanks 01:05 | — | |
| AI DeepSeek BiotechnologyDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $61.00 → $62.00+1.6% | Hold | +0.1% | Reiterated | 09.10.26on TipRanks 16:05 | — | |
| AI OpenAI BiotechnologyOpenAI 5.2 | TipRanks - OpenAI | $61.00 → $62.00+1.6% | Hold | +0.1% | Reiterated | 09.10.26on TipRanks 16:05 | — | |
| AI Google BiotechnologyGemini 3.1Pro | TipRanks - Google | $64.00 → $65.00+1.6% | Hold | +4.9% | Reiterated | 09.10.26on TipRanks 16:05 | — | |
| AI PerPlexity BiotechnologyPerPlexity SonarPro | TipRanks - PerPlexity | $61.00 → $62.00+1.6% | Hold | +0.1% | Reiterated | 09.10.26on TipRanks 16:05 | — | |
| Leonid Timashev★★★★★★★★★★#279 · hits 60% · avg +24.5% | RBC Capital | $112 → $113+0.9% | Buy | +82.4% | Reiterated | 08.10.26on TipRanks 09:05 | +1.9%next day +0.9% · 5 days +3.4% | ↗ |
| AI xAi BiotechnologyxAI Grok-4 | TipRanks - xAI | $62.00 → $61.00−1.6% | Hold | −1.5% | Reiterated | 07.10.26on TipRanks 10:05 | — | |
| AI DeepSeek BiotechnologyDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $62.00 → $61.00−1.6% | Hold | −1.5% | Reiterated | 07.10.26on TipRanks 10:05 | — | |
| AI OpenAI BiotechnologyOpenAI 5.2 | TipRanks - OpenAI | $62.00 → $61.00−1.6% | Hold | −1.5% | Reiterated | 07.10.26on TipRanks 10:05 | — | |
| AI Anthropic BiotechnologyAnthropic Opus-4.6 | TipRanks - Anthropic | $62.00 → $61.00−1.6% | Hold | −1.5% | Reiterated | 07.10.26on TipRanks 10:05 | — | |
| AI Google BiotechnologyGemini 3.1Pro | TipRanks - Google | $66.00 → $64.00−3.0% | Hold | +3.3% | Reiterated | 07.10.26on TipRanks 10:05 | — | |
| AI PerPlexity BiotechnologyPerPlexity SonarPro | TipRanks - PerPlexity | $62.00 → $61.00−1.6% | Hold | −1.5% | Reiterated | 07.10.26on TipRanks 10:05 | — | |
| AI xAi BiotechnologyxAI Grok-4 | TipRanks - xAI | $64.00 → $62.00−3.1% | Hold | +0.1% | Reiterated | 06.10.26on TipRanks 01:05 | — | |
| AI DeepSeek BiotechnologyDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $64.00 → $62.00−3.1% | Hold | +0.1% | Reiterated | 06.10.26on TipRanks 01:05 | — | |
| AI OpenAI BiotechnologyOpenAI 5.2 | TipRanks - OpenAI | $64.00 → $62.00−3.1% | Hold | +0.1% | Reiterated | 06.10.26on TipRanks 01:05 | — | |
| AI Anthropic BiotechnologyAnthropic Opus-4.6 | TipRanks - Anthropic | $64.00 → $62.00−3.1% | Hold | +0.1% | Reiterated | 06.10.26on TipRanks 01:05 | — | |
| AI Google BiotechnologyGemini 3.1Pro | TipRanks - Google | $68.00 → $66.00−2.9% | Hold | +6.5% | Reiterated | 06.10.26on TipRanks 01:05 | — | |
| AI PerPlexity BiotechnologyPerPlexity SonarPro | TipRanks - PerPlexity | $64.00 → $62.00−3.1% | Hold | +0.1% | Reiterated | 06.10.26on TipRanks 01:05 | — | |
| Joseph Pantginis★★★★★★★★★★#243 · hits 55% · avg +24.8% | H.C. Wainwright | $140 | Buy | +126.0% | Reiterated | 05.10.26on TipRanks 11:30 | −5.1%next day −2.7% · 5 days −0.3% | ↗ |
| Serge Belanger★★★★★★★★★★#674 · hits 49% · avg +14.9% | Needham | $112 | Buy | +80.8% | Reiterated | 05.10.26on TipRanks 06:25 | −5.1%next day −2.7% · 5 days −0.3% | ↗ |
| Yanan Zhu★★★★★★★★★★#1136 · hits 36% · avg +15.3% | Wells Fargo | $105 | Buy | +69.5% | Reiterated | 02.10.26on TipRanks Oct 3 13:30 | −0.8%next day −5.1% · 5 days −5.3% | ↗ |
| Joseph Pantginis★★★★★★★★★★#243 · hits 55% · avg +24.8% | H.C. Wainwright | $140 | Buy | +126.0% | Reiterated | 30.09.26on TipRanks 10:35 | +0.6%next day −0.6% · 5 days −9.2% | ↗ |
| Serge Belanger★★★★★★★★★★#674 · hits 49% · avg +14.9% | Needham | $112 | Buy | +80.8% | Reiterated | 29.09.26on TipRanks 05:15 | −0.6%next day +0.6% · 5 days −8.5% | ↗ |
| AI xAi BiotechnologyxAI Grok-4 | TipRanks - xAI | $64.00 | Hold | +3.3% | Reiterated | 28.09.26on TipRanks 15:05 | — | |
| AI DeepSeek BiotechnologyDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $64.00 | Hold | +3.3% | Reiterated | 28.09.26on TipRanks 15:05 | — | |
| AI OpenAI BiotechnologyOpenAI 5.2 | TipRanks - OpenAI | $64.00 | Hold | +3.3% | Reiterated | 28.09.26on TipRanks 15:05 | — | |
| AI Anthropic BiotechnologyAnthropic Opus-4.6 | TipRanks - Anthropic | $64.00 | Hold | +3.3% | Reiterated | 28.09.26on TipRanks 15:05 | — | |
| AI Google BiotechnologyGemini 3.1Pro | TipRanks - Google | $68.00 | Hold | +9.8% | Reiterated | 28.09.26on TipRanks 15:05 | — | |
| AI PerPlexity BiotechnologyPerPlexity SonarPro | TipRanks - PerPlexity | $64.00 | Hold | +3.3% | Reiterated | 28.09.26on TipRanks 15:05 | — | |
| Leonid Timashev★★★★★★★★★★#279 · hits 60% · avg +24.5% | RBC Capital | $112 | Buy | +80.8% | Reiterated | 10.09.26on TipRanks 08:25 | −0.1%next day −0.6% · 5 days −5.7% | ↗ |
| Srikripa Devarakonda★★★★★★★★★★#200 · hits 62% · avg +26.3% | Truist Financial | $112 | Buy | +80.8% | Reiterated | 01.09.26on TipRanks 07:30 | +1.4%next day +0.3% · 5 days +3.7% | ↗ |
| Cory Kasimov★★★★★★★★★★#276 · hits 59% · avg +18.9% | Evercore ISI | $100 | Buy | +61.4% | Reiterated | 31.08.26on TipRanks 09:15 | −1.3%next day +1.4% · 5 days +6.4% | ↗ |
| Jason Zemansky★★★★★★★★★★#467 · hits 60% · avg +21.6% | Bank of America Securities | $85.00 | Hold | +37.2% | Reiterated | 31.08.26on TipRanks 06:35 | −1.3%next day +1.4% · 5 days +6.4% | ↗ |
| Paul Choi★★★★★★★★★★#1415 · hits 56% · avg +9.6% | Goldman Sachs | $105 | Buy | +69.5% | Reiterated | 28.08.26on TipRanks Aug 31 03:45 | −7.2%next day −1.3% · 5 days +0.8% | ↗ |
| Emily Field★★★★★★★★★★#5009 · hits 45% · avg +1.9% | Barclays | $110 | Buy | +77.6% | Reiterated | 26.08.26on TipRanks Aug 27 04:45 | +2.2%next day −2.3% · 5 days −9.1% | ↗ |
| Tessa Romero★★★★★★★★★★#805 · hits 57% · avg +21.7% | J.P. Morgan | — | Buy | — | Reiterated | 20.08.26on TipRanks 08:55 | +0.1%next day −0.8% · 5 days −0.2% | ↗ |
| Yasmeen Rahimi★★★★★★★★★★#160 · hits 51% · avg +36.0% | Piper Sandler | $107 | Buy | +72.7% | Reiterated | 07.08.26on TipRanks 11:27 | −6.3%next day +1.0% · 5 days −3.8% | ↗ |
| James Condulis★★★★★★★★★★#3810 · hits 56% · avg +8.9% | Stifel Nicolaus | $108 | Buy | +74.3% | Reiterated | 07.08.26on TipRanks 08:15 | −6.3%next day +1.0% · 5 days −3.8% | ↗ |
| Jason Butler★★★★★★★★★★#412 · hits 51% · avg +18.3% | Citizens JMP | $105 → $110+4.8% | Buy | +77.6% | Reiterated | 07.08.26on TipRanks 06:20 | −6.3%next day +1.0% · 5 days −3.8% | ↗ |
| Mayank Mamtani★★★★★★★★★★#2653 · hits 38% · avg +5.8% | B. Riley Securities | $146 | Buy | +135.7% | Reiterated | 31.07.26on TipRanks 08:42 | −4.8%next day −2.3% · 5 days −4.0% | ↗ |
| Maxwell Skor★★★★★★★★★★#486 · hits 74% · avg +28.0% | Morgan Stanley | $103 | Buy | +66.3% | Assigned | 23.07.26on TipRanks 21:16 | −1.5%next day −0.2% · 5 days −5.6% | ↗ |
| Eric Joseph★★★★★★★★★★#1258 · hits 52% · avg +11.4% | Citi | $99.00 | Buy | +59.8% | Reiterated | 16.07.26on TipRanks 07:08 | −2.2%next day +0.8% · 5 days +3.6% | ↗ |
| Ashwani Verma★★★★★★★★★★#1305 · hits 60% · avg +13.4% | UBS | $115 | Buy | +85.6% | Upgrade | 29.06.26on TipRanks 06:05 | +4.5%next day −3.2% · 5 days −2.9% | ↗ |
| Salim Syed★★★★★★★★★★#7609 · hits 44% · avg +0.2% | Mizuho Securities | $100 → $118+18.0% | Buy | +90.5% | Reiterated | 23.06.26on TipRanks 10:10 | +2.5%next day +1.5% · 5 days +4.7% | ↗ |
| Yanan Zhu★★★★★★★★★★#1136 · hits 36% · avg +15.3% | Wells Fargo | $95.00 → $105+10.5% | Buy | +69.5% | Reiterated | 07.05.26on TipRanks 07:10 | −0.4%next day +2.7% · 5 days +3.6% | ↗ |
| Unknown Analyst | Raymond James | — | Hold | — | Reiterated | 06.05.26on TipRanks May 7 05:30 | −4.3%next day −0.4% · 5 days +2.0% | ↗ |
| Carter Gould★★★★★★★★★★#2194 · hits 53% · avg +6.3% | Cantor Fitzgerald | — | Buy | — | Reiterated | 25.02.26on TipRanks Feb 26 09:40 | −11.1%next day +0.1% · 5 days +0.2% | ↗ |
| Roanna Ruiz★★★★★★★★★★#9351 · hits 46% · avg −0.3% | Leerink Partners | — | Buy | — | Reiterated | 13.01.26on TipRanks Jan 14 02:51 | −1.8%next day +2.5% · 5 days +0.7% | ↗ |
| No ratings for this filter. | ||||||||
Every rating the collector has kept for the last 12 months, including the earlier ones of the same analyst. Latest of each analyst
Best analysts covering Cytokinetics
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $111 at a price of $65.91 (+67.9%); now: $111 at $61.95 (+78.6%).
PriceAverage targetTop analysts’ target
Recommendation trend
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 4 | 5 | 7 | 12 | 17 |
| Buy | 20 | 24 | 22 | 26 | 19 | 17 |
| Hold | 6 | 4 | 3 | 5 | 4 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 29.10.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $-1.45 (from $-1.65 to $-1.10). Last quarter: $-1.50.
Sales
Next quarter’s sales estimate — $41M (from $28M to $57M). Last quarter: $29M.
Best top-analyst consensus in the sector · Healthcare
About Cytokinetics
- CEO: Robert I. Blum
- Employees: 673
- 350 Oyster Point Boulevard, South San Francisco, CA, 94080, US
- www.cytokinetics.com
Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. The company markets MYQORZO, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of symptomatic oHCM. It also develops Aficamten, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of HCM; and omecamtiv mecarbil, a potential treatment across the continuum of care in heart failure with severely reduced ejection fraction. In addition, the company is involved in developing and Ulacamten, a novel, selective, oral, and small molecule cardiac myosin inhibitor designed to reduce the hypercontractility associated with heart failure with preserved ejection fraction in Phase 1 clinical trials; and CK-089, a fast skeletal muscle troponin activator in Phase 1 clinical trials. Cytokinetics, Incorporated was incorporated in 1997 and is headquartered in South San Francisco, California.
Data from the stock’s TipRanks forecast page, read 43 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗